iKang Healthcare Group, Inc. (KANG) Upgraded to “Sell” by BidaskClub

BidaskClub upgraded shares of iKang Healthcare Group, Inc. (NASDAQ:KANG) from a strong sell rating to a sell rating in a research report released on Saturday, August 5th.

Shares of iKang Healthcare Group (NASDAQ KANG) traded up 1.66% during mid-day trading on Friday, reaching $14.11. 136,195 shares of the company traded hands. iKang Healthcare Group has a 52-week low of $11.70 and a 52-week high of $19.20. The company’s 50 day moving average is $12.79 and its 200 day moving average is $14.54.

iKang Healthcare Group (NASDAQ:KANG) last issued its quarterly earnings results on Thursday, June 22nd. The medical research company reported ($0.49) earnings per share (EPS) for the quarter. iKang Healthcare Group had a negative return on equity of 3.19% and a negative net margin of 2.58%. The business had revenue of $60.16 million during the quarter. On average, equities analysts predict that iKang Healthcare Group will post $0.65 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “iKang Healthcare Group, Inc. (KANG) Upgraded to “Sell” by BidaskClub” was reported by BNB Daily and is the property of of BNB Daily. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/ikang-healthcare-group-inc-kang-rating-increased-to-sell-at-bidaskclub-updated.html.

A number of hedge funds have recently modified their holdings of KANG. First Manhattan Co. raised its stake in shares of iKang Healthcare Group by 101.7% in the second quarter. First Manhattan Co. now owns 1,040,043 shares of the medical research company’s stock worth $12,761,000 after buying an additional 524,318 shares during the last quarter. Athos Capital Ltd acquired a new stake in shares of iKang Healthcare Group during the second quarter worth about $8,622,000. GLG Partners LP raised its stake in shares of iKang Healthcare Group by 15.5% in the second quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock worth $21,529,000 after buying an additional 235,056 shares during the last quarter. FIL Ltd raised its stake in shares of iKang Healthcare Group by 45.4% in the second quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock worth $4,429,000 after buying an additional 112,615 shares during the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of iKang Healthcare Group by 14.6% in the second quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock worth $547,000 after buying an additional 5,700 shares during the last quarter. 31.60% of the stock is currently owned by hedge funds and other institutional investors.

About iKang Healthcare Group

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply